Gebo Joins ‘All of Us’ Research Program
Dr. Kelly Gebo has joined the All of Us Research Program as chief medical and scientific officer.
She will work with health care professionals and researchers, participants and national and community-based organizations to lead the program’s scientific agenda, with a special focus on populations that have been historically underrepresented in research.
“Kelly has the right combination of research skills, leadership experience and passion for personalized medicine for the job,” said Eric Dishman, director of the program. “I’m delighted to have her join our team in this new position.”
Gebo has clinical, research and educational experience in the health care and higher education sectors. She is a professor of medicine at Johns Hopkins University and an expert in HIV health services research and clinical outcomes of persons with HIV. She has served as co-principal investigator of the HIV Research Network, an 18-year clinical cohort study of high-volume HIV sites caring for more than 20,000 persons with HIV across the country. Her research has been funded through NIH, the Agency for Healthcare Research and Quality and the Health Resources and Services Administration.
Gebo has authored over 150 peer-reviewed publications, is an elected member of the American Society for Clinical Investigation and has received numerous national awards for her research and teaching.
She is also a leader in higher education, previously serving as an American Council on Education fellow at the University of Pennsylvania and as vice provost for education at Johns Hopkins.
Gebo holds a doctorate in medicine from Johns Hopkins University School of Medicine and a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She did her internal medicine residency at Johns Hopkins and completed fellowship training in both the Robert Wood Johnson Foundation Clinical Scholars program and in the infectious diseases fellowship training program at Johns Hopkins.
Gebo will maintain her faculty appointment at Johns Hopkins concurrent with her NIH role.